Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel cytotoxic protein derived from bacterial source

Jan. 24, 1997

Cell adhesion inhibitors claimed by Nippon Shinyaku

Jan. 23, 1997

Development partners sought for novel antimitotic agents

Jan. 22, 1997

NYU seeks partners for development of potential anticancer/antiinflammatory therapies

Jan. 22, 1997

Collaborators sought for development of combination chemotherapy approach

Jan. 22, 1997

CRADA offered for new metastasis gene therapy

Jan. 22, 1997

MDI offers potential anticancer agent for licensing

Jan. 22, 1997

Research suggests potential of anti-DNA MeTase antisense compounds

Jan. 22, 1997

URSO to be evaluated as chemopreventive for colorectal cancer

Jan. 21, 1997

Function of breast cancer gene described

Jan. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...